Variable | Data Subset | OR | 95% CI of OR | p Value | Covariate (s) | aORa | 95% CI of aOR | p Value |
---|---|---|---|---|---|---|---|---|
AMCL started | All Patients | 1.547 | 1.089–2.197 | 0.02* | UDS fentanyl POS | 1.259 | 0.751–2.109 | 0.38 |
During COVIDb | All Patients | 2.132 | 1.360–3.343 | < 0.001* | AMCL started; UDS fentanyl POS | 2.325 | 1.006–5.371 | 0.05* |
UDS fentanyl POS | All Patients | 12.056 | 6.636–21.901 | < 0.001* | UDS oxy POS; UDS opiates POS; Patient race-White; OUD dx | 5.800 | 2.758–12.198 | < 0.001* |
UDS fentanyl POS | OUD dx | 2.947 | 1.099–7.902 | 0.03* | UDS oxy POS; UDS opiates POS; Patient race-White | 3.259 | 1.199–8.858 | 0.02* |
UDS fentanyl POS | No OUD dx | 11.493 | 4.164–31.722 | < 0.001* | UDS oxy POS; UDS opiates POS; Patient race-White | 7.089 | 2.481–20.252 | < 0.001* |
65yo or older | All Patients | 0.152 | 0.037–0.617 | 0.008* | UDS fentanyl POS; UDS oxy POS; UDS opiates POS | 0.212 | 0.029–1.557 | 0.13 |
OUD dx | All Patients | 11.843 | 8.016–17.496 | < 0.001* | UDS fentanyl POS; UDS oxy POS; UDS opiates POS | 5.482 | 2.885–10.418 | < 0.001* |
Co-occurring Psych dx | All Patients | 0.300 | 0.178–0.506 | < 0.001* | UDS fentanyl POS | 0.513 | 0.281–0.935 | 0.03* |
Co-occurring chronic medical condition | All Patients | 0.245 | 0.158–0.382 | < 0.001* | 65yo or older; OUD dx; UDS fentanyl POS | 0.629 | 0.357–1.106 | 0.11 |
Uninsured | All Patients | 2.532 | 1.792–3.576 | < 0.001* | UDS fentanyl POS | 1.271 | 0.769–2.100 | 0.35 |
Medicaid | All Patients | 0.410 | 0.249–0.674 | < 0.001* | UDS fentanyl POS | 0.693 | 0.359–1.339 | 0.28 |
Medicare | All Patients | 0.447 | 0.252–0.793 | 0.006* | UDS fentanyl POS | 0.603 | 0.258–1.409 | 0.24 |
Private insurance | All Patients | 0.884 | 0.483–1.619 | 0.69 | ||||
Patient race-White | All Patients | 3.157 | 2.153–4.630 | < 0.001* | UDS fentanyl POS; OUD dx | 1.278 | 0.723–2.261 | 0.40 |
Patient race-Black | All Patients | 0.283 | 0.189–0.423 | < 0.001* | UDS fentanyl POS; OUD dx | 0.669 | 0.368–1.217 | 0.19 |
Patient race-Black | OUD dx | 0.832 | 0.473–1.464 | 0.52 | ||||
Patient race-White | OUD dx | 0.995 | 0.545–1.815 | 0.99 | ||||
UDS amp POS | All Patients | 2.685 | 1.522–4.763 | < 0.001* | UDS fentanyl pos | 1.254 | 0.693–2.269 | 0.45 |
UDS fentanyl POS | UDS amp POS | 4.860 | 1.632–14.469 | 0.005* | OUD dx | 3.388 | 1.091–10.522 | 0.04* |
UDS benzo POS | All Patients | 1.766 | 0.931–3.347 | 0.08 | ||||
UDS fentanyl POS | UDS benzo POS | 13.401 | 1.733–103.640 | 0.01* | OUD dx | 9.425 | 1.178–75.440 | 0.04* |
UDS cocaine POS | All Patients | 1.218 | 0.632–2.345 | 0.56 | ||||
UDS fentanyl POS | UDS cocaine POS | 6.899 | 2.055–23.163 | 0.002* | OUD dx | 2.519 | 0.644–9.852 | 0.18 |
UDS opiates POS | All Patients | 5.606 | 3.179–9.883 | < 0.001* | UDS fentanyl pos | 3.135 | 1.740–5.647 | < 0.001* |
UDS fentanyl POS | UDS opiates POS | 4.767 | 1.776–12.793 | 0.002* | OUD dx | 3.687 | 1.341–10.141 | 0.01* |
UDS oxy POS | All Patients | 6.876 | 3.803–12.429 | < 0.001* | UDS fentanyl pos | 4.385 | 2.385–8.060 | < 0.001* |
Unhousedc | Discharge dx SUD and UDS fentanyl POS | 0.685 | 0.202–2.328 | 0.54 | ||||
UDS amp POS | UDS Fentanyl POS | 1.008 | 0.530–1.915 | 0.98 | ||||
UDS opiates | UDS Fentanyl POS | 2.506 | 1.316–4.770 | 0.005* | OUD dx | 1.570 | 0.791–3.118 | 0.20 |
UDS oxy POS | UDS Fentanyl POS | 3.126 | 1.568–6.233 | 0.001* | OUD dx | 2.425 | 1.192–4.934 | 0.01* |